Hjertesykdom hos kvinner er vårt overbyggende forskningsfokus. Hjertesykdom hos kvinner undersøkes i samarbeid med internasjonale partnere i Tyskland, Italia og USA. Hovedfokus er hjertesykdom som følge av høyt blodtrykk, aortaklaffestenose, fedme og autoimmune sykdommer, og hvordan disse faktorene belaster hjertet ulikt hos kvinner og menn. Vår forskning har bidratt til nye europeiske anbefalinger om behandling av høyt blodtrykk hos pasienter med aortaklaffstenose, og et internasjonalt fokus på hjertesykdom hos kvinner. Dette forsker vi på i norske befolkningsundersøkelser og i prosjekter med kliniske studier av personer med høyt blodtrykk, fedme, aortaklaffestenose, autoimmune sykdommer eller iskemisk hjerneslag. Et nytt Senter for forskning på hjertesykdom hos kvinner ble opprettet ved UiB juni 2020 finansiert av Hjertefondet ved UiB, Bergen Sanitetskvinner/Norske Kvinners Sanitetsforening og Grieg Foundation (https://www.uib.no/kvinnehjerte). Vår videre forskning vil tilknyttes Senterets nettverk.

Helseundersøkelsen i Hordaland - runde 3 (HUSK3) ble gjennomført 2018-22. Hovedfokus er hva blodtrykk og andre helsefaktorer og endring i disse mens man er i 40-årene betyr for hjerte-kar helsen 20 år senere. Prosjektet er et samarbeid mellom 4 forskergrupper på UiB ledet av henholdsvis professor Grethe S. Tell, professor Ottar Nygård, professor Jutta Dierkes, undertegnede, BEVITAL akademisk laboratorium og Høgskolen på Vestlandet ved professor Marjolein Iversen. Se også: stipendiat Ester Kringeland, UiB og stipendiat Annabel E. Ohldieck, UiB og deres banebrytende publikasjoner.

Ukontrollert høyt blodtrykk er et stort helseproblem i Norge. I samarbeid med de 4 øvrige universiteter forsker vi på dette i IDA studien. I samarbeid med overlege PhD Marianne Grytaas, endokrinologisk seksjon, medisinsk avdeling, Haukeland Universitetssykehus forsker vi på pasienter med primær aldosteronisme som underliggende årsak til høyt blodtrykk. Vårt hovedfokus er hvordan ukontrollert høyt blodtrykk påvirker hjertet, og om påvirkningen er forskjellig hos kvinner og menn eller utfra hva årsaken til det høye blodtrykket er. Se også: stipendiat Arleen Aune, UiB

Kvinner med autoimmune sykdommer har høy risiko for å få hjertesykdom tidlig. I samarbeid med revmatologisk avdeling, Haukeland Universitetssykehus studerer vi hjerteeffekten av moderne immunmodulerende behandling ved leddgikt. Se også: seniorforsker Helga Midtbø PhD, UiB og Haukeland Universitetssykehus, og stipendiat Anja G. Linde, UiB

Subklinisk hjertekarsykdom hos unge slagpasienter undersøkes i NOR-SYS prosjektet i samarbeid med professor Ulrike Waje-Andreassen, nevrologisk avdeling, Haukeland Universitetssykehus som ble startet i 2010. Oppfølgingsundersøkelsene ved Hjerteavdelingen ble fullført 2022. Hjerteultralydbilder fra den europeiske studien SECRETO på slagpasienter under 50 år sendes for analyse i våre kjernelaboratorium. Se også stipendiat Rune Eilertsen, UiB som er tilknyttet prosjektet.

Kommentar til Kildens rapport om manglende kjønnsperspektiv i norsk hjerteforskning

https://kjonnsforskning.no/nb/2023/01/medisinske-studier-ser-bort-fra-kjonnsforskjeller

Høyt blodtrtykk farligere for kvinnehjertet VG oppslag

https://www.vg.no/nyheter/innenriks/i/l3zqWL/fersk-rapport-kvinner-har-dobbelt-saa-stor-risiko-for-hjerteinfarkt-naar-blodtrykket-stiger

Tildeling av Nasjonalforeningens hjerteforskningspris 2022

https://forskning.no/demens-forskningspriser-hjernen/kongen-delte-ut-forskningspriser/2018501

Oppslag i Samfunnsviteret 25.05.21

– Data som er samlet inn om menn kan ikke, og bør ikke, gjelde for kvinner – Samfunnsviteren

Kronikk Bergens Tidende 05.07.20

https://www.bt.no/btmeninger/debatt/i/6jxy13/kampen-om-kvinnehjertet

Intervju Undervisning i kvinnehelse i utdanning av helsearbeidere Dagsnytt 18, 16.04.20

https://tv.nrk.no/serie/dagsnytt-atten-tv/202004/NNFA56041620/avspiller

 

Intervju Ensomhet og kvinnehjertehelse Gro Holm NRK P1

https://radio.nrk.no/serie/holm/DMTO01024519

 

Hjertepraten, Litteraturhuset i Bergen 15.08.18

– Store kjønnsforskjeller ved hjerteinfarkt

Menn og kvinner har forskjellige risikofaktorer, symptomer og typer hjerteinfarkt, påpeker professor Eva Gerdts ved Klinisk institutt 2. Onsdag 15. august holder hun foredrag om temaet på Litteraturhuset i Bergen. Se innlegget på https://www.uib.no/med/119381/–-store-kjønnsforskjeller-ved-hjerteinfarkt eller på https://www.youtube.com/watch?v=t2lwuNonhOA.

https://forskning.no/nasjonal-kompetansetjeneste-for-kvinnehelse-kjonn-og-samfunn-hjertet/seks-ting-alle-kvinner-bor-vite-om-hjerteinfarkt/1202059 

 

Kvinnehjerter - en fagbok om vanlige hjertesykdommer

Løchen ML og Gerdts E. 2015, Oslo (Gyldendal Akademisk). ISBN: 978-8-205-46397-4. Boken kan bestilles ved å sende SMS med kodeord kvinnehjerter til 2030. Pris NOK 425

 

Underviser i profesjonsutdanning av leger ved UiB, semester MED5, MED11 og MED12. Undervisningen omfatter et praktisk kurs i hjerteultralydundersøkelse med håndholdt ultralydapparat, og forelesninger om høyt blodtrykk, hypertertensiv hjertesykdom og hjertesykdom hos kvinner. Organiserer fagdager om hjerteklaffsykdom hos eldre og symptomet tungpust.

PhD kurs NORHEART901 Cardiovascular imaging in research. Kursleder.

Underviser på nasjonale kurs i spesialistutdanning i indremedisin, nyresykdommer og hjertesykdommer

Vitenskapelig litteraturgjennomgang

• Eva Gerdts; Susana Novella; Yvan Devaux et al. (2025). Biological Sex and Cardiovascular Disease Prevention in Systemic Arterial Hypertension. (ekstern lenke)
• John William McEvoy; Cian P. McCarthy; Rosa Maria Bruno et al. (2024). 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. (ekstern lenke)
• Cinzia Perrino; Péter Ferdinandy; Hans Erik Bøtker et al. (2021). Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: Position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart. (ekstern lenke)
• Tijana Mitić; Adriana Georgescu; Nicoleta Alexandru-Moise et al. (2025). Current status and challenges of multi-omics research using animal models of atherosclerosis. (ekstern lenke)
• Susana Novella; Eva Gerdts; Georgios Kararigas (2025). Divergent mechanisms of cardiovascular remodeling between men and women. (ekstern lenke)
• Costantino Mancusi; Giovanni de Simone; Jana Brguljan Hitij et al. (2020). Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (ekstern lenke)
• Costantino Mancusi; Edda Bahlmann; Christian Basile et al. (2022). New Evidence About Aortic Valve Stenosis and Cardiovascular Hemodynamics. (ekstern lenke)
• Eva Gerdts; Vera Regitz-Zagrosek (2019). Sex differences in cardiometabolic disorders. (ekstern lenke)
• Miron Sopic; Baiba Vilne; Eva Gerdts et al. (2023). Multiomics tools for improved atherosclerotic cardiovascular disease management. (ekstern lenke)
• Ingrid Os; S Oparil; E Gerdts et al. (2004). Essential hypertension in women. (ekstern lenke)
• Sahrai Saeed; Eva Gerdts (2018). Managing complications of hypertension in aortic valve stenosis patients. (ekstern lenke)
• Mai Tone Lønnebakken; Eva Gerdts (2010). Impact of ultrasound contrast agents in echocardiographic assessment of ischemic heart disease. (ekstern lenke)
• Dana Cramariuc; Eva Gerdts (2016). Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic. (ekstern lenke)
• Eva Gerdts; Isabella Sudano; Sofie Brouwers et al. (2022). Sex differences in arterial hypertension. (ekstern lenke)
• Valeria Valim; Eva Gerdts; Roland Jonsson et al. (2016). Atherosclerosis in Sjögren's syndrome: Evidence, possible mechanisms and knowledge gaps. (ekstern lenke)
• Dana Cramariuc; Edda Bahlmann; Eva Gerdts (2022). Grading of Aortic Stenosis: Is it More Complicated in Women?. (ekstern lenke)
• Giovanni de Simone; Raffaele Izzo; Nicola De Luca et al. (2013). Left ventricular geometry in obesity: Is it what we expect?. (ekstern lenke)

Vitenskapelig artikkel

• Anja Linde; Eva Gerdts; Bjørg Tilde Svanes Fevang et al. (2025). Factors associated with left ventricular mass during disease modifying antirheumatic drug therapy in patients with rheumatoid arthritis: the Joint Heart study. (ekstern lenke)
• Nina Jaakonmäki; Tuukka Helin; Timea Szanto et al. (2025). Anti-beta2-glycoprotein I IgG antibodies are associated with early-onset cryptogenic ischemic stroke. (ekstern lenke)
• Agata Bielecka-Dabrowa; Marta Michalska-Kasiczak; Anna Gluba et al. (2015). Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension. (ekstern lenke)
• Johannes Just Hjertaas; Eigir Einarsen; Eva Gerdts et al. (2023). Impact of aortic valve stenosis on myocardial deformation in different left ventricular levels: A three-dimensional speckle tracking echocardiography study. (ekstern lenke)
• Anders M. Greve; Eva Gerdts; Kurt Boman et al. (2011). Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study. (ekstern lenke)
• Eva Gerdts; Lasse Oikarinen; Vittorio Palmieri et al. (2002). Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. (ekstern lenke)
• R. B. Devereux; J. N. Bella; K. Boman et al. (2001). Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. (ekstern lenke)
• RB Devereux; MJ Roman; V Palmieri et al. (2000). Left ventricular wall stresses and stress-mass products in hypertensive patients with electrocardiographic left ventricular hypertrophy. (ekstern lenke)
• Ingeborg Eskerud; Eva Gerdts; Jan Erik Nordrehaug et al. (2015). Global coronary artery plaque area is associated with myocardial hypoperfusion in women with non-ST elevation myocardial infarction. (ekstern lenke)
• Annette Fromm; Lars Thomassen; Halvor Næss et al. (2013). The Norwegian stroke in the young study (NOR-SYS): rationale and design. (ekstern lenke)
• Vittorio Palmieri; Jonathan N. Bella; Mary J Roman et al. (2003). Pulse pressure/stroke index and left ventricular geometry and function:the Life Study. (ekstern lenke)
• Mai Tone Lønnebakken; Raffaele Izzo; Costantino Mancusi et al. (2016). Aortic root dimension and arterial stiffness in arterial hypertension: The Campania Salute Network. (ekstern lenke)
• Lisa Marie Dale Grymyr; Saied Nadirpour; Eva Gerdts et al. (2020). Left ventricular myocardial oxygen demand and subclinical dysfunction in patients with severe obesity referred for bariatric surgery. (ekstern lenke)
• Jukka Putaala; Nicolas Martinez-Majander; Sahrai Saeed et al. (2017). Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design. (ekstern lenke)
• Astrid Strandheim; Hilde Halland; Sahrai Saeed et al. (2015). Obesity-associated metabolic changes influence resting and peak heart rate in women and men. (ekstern lenke)
• I. Os; S. Oparil; Eva Gerdts et al. (2004). Essential hypertension in women. (ekstern lenke)
• K. Wachtell; V. Papademetriou; G. Smith et al. (2004). Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. (ekstern lenke)
• V Palmieri; K. Wachtell; J.N. Bella et al. (2004). Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study. (ekstern lenke)
• Eva Gerdts; Lodve Stangeland; H. Engedal et al. (1994). Postoperative Doppler echocardiograpic evaluation in different sizes of Medtronic-Hall, Biocor and Carpentier-Edwards s.a.v. prosthetic-aortic valves. (ekstern lenke)
• Rasmus Bach Sindre; Eva Gerdts; Jukka Putaala et al. (2024). Association of Left Atrial Stiffness With Risk of Cryptogenic Ischemic Stroke in Young Adults. (ekstern lenke)
• Eirik Olsen; Lene Vernås Halvorsen; Stine Rognstad et al. (2025). Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study. (ekstern lenke)
• Costantino Mancusi; Eva Gerdts; Giovanni de Simone et al. (2016). Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy: the LIFE study. (ekstern lenke)
• Helga Bergljot Midtbø; Anne Grete Semb; Knut Matre et al. (2018). Left Ventricular Systolic Myocardial Function in Ankylosing Spondylitis. (ekstern lenke)
• Eva Gerdts; Anne Bjørhovde Rossebø; Terje Rolf Pedersen et al. (2010). Impact of Baseline Severity of Aortic Valve Stenosis on Effect of Intensive Lipid Lowering Therapy (from the SEAS Study). (ekstern lenke)
• Mai Tone Lønnebakken; Giovanni de Simone; Sahrai Saeed et al. (2017). Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis. (ekstern lenke)
• Casper N. Bang; Eva Gerdts; Gerard P. Aurigemma et al. (2014). Four-group classifcation of left ventricular hypertrophy based on ventricular concentricity and dilatation identifes a low-risk subset of eccentric hypertrophy in hypertensive patients. (ekstern lenke)
• Hilde Halland; Mai Tone Lønnebakken; Sahrai Saeed et al. (2017). Does fitness improve the cardiovascular risk profile in obese subjects?. (ekstern lenke)
• Richard B. Devereux; Casper N. Bang; Mary J. Roman et al. (2015). Left ventricular wall stress-mass-heart rate product and cardiovascular events in treated hypertensive patients: Life study. (ekstern lenke)
• Marina De Marco; Eva Gerdts; Giuseppina Casalnuovo et al. (2013). Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: The LIFE study. (ekstern lenke)
• Dana Cramariuc; Barbara Rogge; Mai Tone Lønnebakken et al. (2015). Sex differences in cardiovascular outcome during progression of aortic valve stenosis. (ekstern lenke)
• Eigir Einarsen; Eva Gerdts; Ulrike Waje-Andreassen et al. (2020). Association of increased arterial stiffness with diastolic dysfunction in ischemic stroke patients the Norwegian Stroke in the Young Study. (ekstern lenke)
• Jukka Putaala; Bettina von Sarnowski; Ulf Schminke et al. (2024). Association of Hypertension With Early-Onset Cryptogenic Ischemic Stroke by the Presence of Patent Foramen Ovale: A Case-Control Study. (ekstern lenke)
• Eva Gerdts; Peter M. Okin; Kurt Boman et al. (2012). Association of heart failure hospitalizations with combined electrocardiography and ehocardiography criteria for left ventricular hypertrophy. (ekstern lenke)
• Giuseppina Casalnuovo; Eva Gerdts; Giovanni de Simone et al. (2012). Arterial stiffness is associated with carotid atherosclerosis in hypertensive patients (The Campania Salute Network). (ekstern lenke)
• John Glad Eikås; Eva Gerdts; Hilde Halland et al. (2023). Arterial Stiffness in Overweight and Obesity: Association with Sex, Age, and Blood Pressure. (ekstern lenke)
• Eva Gerdts; Ole Langeland Myking; Per Lund-Johansen et al. (1997). Angiotensin converting enzyme inhibition and alpha<SUB>1</SUB>-receptor blockade as antihypertensive therapy in type-1 diabetic patients. (ekstern lenke)
• Pilly Mussa Chillo; Åshild Elseth Rieck; Johnson Lwakatare et al. (2013). Left atrial volume index as a marker of left ventricular diastolic dysfunction in asymptomatic Tanzanian diabetic patients. (ekstern lenke)
• Costantino Mancusi; Christian Basile; Eva Gerdts et al. (2024). Carotid plaque offsets sex-related differences in cardiovascular risk of young hypertensive patients. (ekstern lenke)
• Einar Skulstad Davidsen; Per Omvik; Tor Hervig et al. (2009). Left ventricular diastolic function in patients with treated haemochromatosis. (ekstern lenke)
• Edda Bahlmann; Eigir Einarsen; Dana Cramariuc et al. (2021). Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis. (ekstern lenke)
• Pauli Pöyhönen; Jouni Kuusisto; Jani Pirinen et al. (2022). Orientation of the Atrial Septum to the Inferior Vena Cava May Contribute to the Persistent Patency of the Foramen Ovale. (ekstern lenke)
• Pauli Pöyhönen; Jouni Kuusisto; Jani Pirinen et al. (2021). Right atrium and cryptogenic ischaemic stroke in the young: A case-control study. (ekstern lenke)
• Marcello Chinali; Gerard P. Aurigemma; Eva Gerdts et al. (2022). Development of systolic dysfunction unrelated to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy. The LIFE Study. (ekstern lenke)
• Åshild Elseth Rieck; Dana Cramariuc; Kurt Boman et al. (2012). Hypertension in Aortic Stenosis Implications for Left Ventricular Structure and Cardiovascular Events. (ekstern lenke)
• Eva Gerdts; Ole Langeland Myking; Per Omvik (1994). Salt sensitive essential hyperdension evaluated by 24 hour ambulatory blood pressure. (ekstern lenke)
• Mai Tone Lønnebakken; Eva Marianne Staal; Jan Erik Nordrehaug et al. (2011). Usefulness of contrast echocardiography for predicting the severity of angiographic coronary disease in non-ST-elevation myocardial infarction. (ekstern lenke)
• Eigir Einarsen; Dana Cramariuc; Mai Tone Lønnebakken et al. (2017). Comparison of frequency of ischemic cardiovascular events in patients with aortic stenosis with versus without asymmetric septal hypertrophy (from the SEAS Trial). (ekstern lenke)
• Dana Cramariuc; Edda Bahlmann; Kenneth Egstrup et al. (2020). Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis. (ekstern lenke)
• K Wachtell; JN Bella; PR Liebson et al. (2000). Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE Study. (ekstern lenke)
• Eva Gerdts; Giovanni de Simone; Barbara Patricia Lund et al. (2013). Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. (ekstern lenke)
• Mai Tone Lønnebakken; Åshild Elseth Rieck; Eva Gerdts (2011). Contrast stress echocardiography in hypertensive heart disease. (ekstern lenke)
• Eva Gerdts; Raffaele Izzo; Costantino Mancusi et al. (2018). Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network). (ekstern lenke)
• Hilde Espnes; Jocasta Ball; Maja-Lisa Løchen et al. (2021). Sex-specific associations between blood pressure and risk of atrial fibrillation subtypes in the tromsø study. (ekstern lenke)
• Eva Gerdts; Richard B. Devereux (2002). Sex differences in left ventricular systolic function. (ekstern lenke)
• Arleen Aune; Annabel Eide Ohldieck; Lene Vernås Halvorsen et al. (2024). Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence. (ekstern lenke)
• Helga Bergljot Midtbø; Eva Gerdts; Tore Kristian Kvien et al. (2015). Disease activity and left ventricular structure in patients with rheumatoid arthritis. (ekstern lenke)
• Eva Gerdts; Hans Bjørnstad; Sigurd Toft et al. (2002). Impact of diastolic Doppler indices on exercise capacity in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). (ekstern lenke)
• RB Devereux; MJ Roman; V Palmieri et al. (2000). Left ventricular wall stresses and stress-mass products in hypertensive patients with electrocardiographic left ventricular hypertrophy. (ekstern lenke)
• V. Palmieri; K. Wachtell; Eva Gerdts et al. (2001). Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study. (ekstern lenke)
• Jan Minners; Christa Gohlke-Baerwolf; Beat A. Kaufmann et al. (2014). Adjusting parameters of aortic valve stenosis severity by body size. (ekstern lenke)
• Ingeborg Eskerud; Eva Gerdts; Terje H Larsen et al. (2019). Left ventricular hypertrophy contributes to Myocardial Ischemia in Non-obstructive Coronary Artery Disease (the MicroCAD study). (ekstern lenke)
• Edda Bahlmann; Eva Gerdts; Eigir Einarsen et al. (2025). Impact of sex-specific thresholds for low flow in assessment of prognosis in concordantly and discordantly graded aortic valve stenosis. (ekstern lenke)
• Mai Tone Lønnebakken; Øyvind Bleie; Elin Strand et al. (2009). Myocardial Contrast Echocardiography in Assessment of Stable Coronary Artery Disease at Intermediate Dobutamine-Induced Stress Level. (ekstern lenke)
• Barbara Rogge; Dana Cramariuc; Mai Tone Lønnebakken et al. (2013). Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis. (ekstern lenke)
• Eva Gerdts; Stanley Franklin; Åshild E.Eidheim Elseth Rieck et al. (2009). Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study). (ekstern lenke)
• Mai Tone Lønnebakken; Eva Gerdts; Jan Wirsching et al. (2009). Ultrasound in evaluation of post-interventional femoral vein obstruction: a case report. (ekstern lenke)
• Eva Gerdts; Anne Bjørhovde Rossebø; Terje Rolf Pedersen et al. (2015). Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis. (ekstern lenke)
• Ekaterina Sharashova; Tom Wilsgaard; Jocasta Ball et al. (2019). Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromsø Study. (ekstern lenke)
• M.H. Olsen; K. Wachtell; J.N. Bella et al. (2004). Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy. (ekstern lenke)
• J.N. Bella; V. Palmieri; K. Wachtell et al. (2004). Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study. (ekstern lenke)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (1998). Is salt sensitivity a temporary phenomenon?. (ekstern lenke)
• Hilde Halland; Knut Matre; Eigir Einarsen et al. (2019). Effect of fitness on cardiac structure and function in overweight and obesity (the FATCOR study). (ekstern lenke)
• Hilde Halland; Mai Tone Lønnebakken; Nadia Pristaj et al. (2018). Sex differences in subclinical cardiac disease in overweight and obesity (the FATCOR study). (ekstern lenke)
• Åshild Oftedal; Eva Gerdts; Ulrike Waje-Andreassen et al. (2018). Prevalence and covariates of uncontrolled hypertension in ischemic stroke survivors: the Norwegian stroke in the young study. (ekstern lenke)
• Arleen Aune; Eva Gerdts; Marina Victorovna Kokorina et al. (2022). Persistent cardiac organ damage in surgically and medically treated primary aldosteronism. (ekstern lenke)
• Jonathan N. Bella; Kristian Wachtell; Kurt Boman et al. (2002). Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). (ekstern lenke)
• Richard B. Devereux; Vittorio Palmieri; Jennifer E. Liu et al. (2002). Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study. (ekstern lenke)
• Edda Bahlmann; Eva Gerdts; Dana Cramariuc et al. (2013). Prognostic Value of Energy Loss Index in Asymptomatic Aortic Stenosis. (ekstern lenke)
• Pilly Mussa Chillo; Johnson Lwakatare; Åshild Elseth Rieck et al. (2014). Prevalence and covariates of abnormal left ventricular geometry in never-treated hypertensive patients in Tanzania. (ekstern lenke)
• Jon Andreas Bratberg; Efraim Bulut; Åshild Elseth Rieck et al. (2014). Determinants of systolic blood pressure response during exercise in overweight subjects. (ekstern lenke)
• Hanna Augedal Os; Silvia Christin Hellerud Rollefstad; Eva Gerdts et al. (2020). Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study. (ekstern lenke)
• Ekaterina Sharashova; Eva Gerdts; Jocasta Ball et al. (2025). Long-term pulse pressure trajectories and risk of incident atrial fibrillation: the Tromsø Study. (ekstern lenke)
• Yuan Lu; Kaveh Hajifathalian; Majid Ezzati et al. (2013). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. (ekstern lenke)
• Dana Cramariuc; Eva Gerdts; Leidulf Segadal (2006). Impact of hypertension on left ventricular hypertrophy regression and exercise capacity in patients operated for aortic valve stenosis. (ekstern lenke)
• Peter M. Okin; Eva Gerdts; Sverre Erik Kjeldsen et al. (2008). Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy. (ekstern lenke)
• Zeinab Bidel; Milad Nazarzadeh; Dexter Canoy et al. (2023). Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis. (ekstern lenke)
• Eva Gerdts (2008). Left ventricular structure in different types of chronic pressure overload. (ekstern lenke)
• Eva Gerdts; Ole Myking; Per Lund-Johansen et al. (1997). Factors influencing LVM in hypertensitive type-1 diabetic patients. (ekstern lenke)
• Mai Tone Lønnebakken; Jan Erik Nordrehaug; Eva Gerdts (2014). No gender difference in the extent of myocardial ischemia in non-ST elevation myocardial infarction. (ekstern lenke)
• Eigir Einarsen; Dana Cramariuc; Edda Bahlmann et al. (2021). Higher Acceleration/Ejection Time Ratio Predicts Impaired Outcome in Aortic Valve Stenosis. (ekstern lenke)
• Kirsti Ytrehus; Stian Ludvigsen; Costantino Mancusi et al. (2021). Heart Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression Associated With Male Sex and Salt-Sensitive Hypertension in the Dahl Rat. (ekstern lenke)
• Ekaterina Sharashova; Eva Gerdts; Jocasta Ball et al. (2022). Sex-specific time trends in incident atrial fibrillation and the contribution of risk factors: the Tromsø Study 1994-2016. (ekstern lenke)
• Christa Gohlke-Bärwolf; Dana Cramariuc; Anne B. Rossebø et al. (2010). Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in aortic stenosis [SEAS] substudy). (ekstern lenke)
• Jale Moradi; Ellen Berggreen; Eva Gerdts et al. (2026). Taxonomic and functional signatures of smoking and periodontitis severity in the subgingival microbiome of older adults. (ekstern lenke)
• Jukka Putaala; Nicolas Martinez-Majander; Michelle Leppert et al. (2025). Burden of Modifiable Risk Factors in Young-Onset Cryptogenic Ischemic Stroke by High-Risk Patent Foramen Ovale. (ekstern lenke)
• K Wachtell; Eva Gerdts; V Palmieri et al. (2010). In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. (ekstern lenke)
• Eva Gerdts; Ester Anne Kringeland; Helga Bergljot Midtbø (2022). Hjertesykdom er vanlig – også hos kvinner. (ekstern lenke)
• Mai Tone Lønnebakken; Gottfried Greve; Elisabeth Leirgul et al. (2008). Brain abscess caused by paradoxical embolization in Ebstein's anomaly. (ekstern lenke)
• GM Balarini; E Zandonade; L Tanure et al. (2016). Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sjögren's syndrome.. (ekstern lenke)
• Costantino Mancusi; Eva Gerdts; Maria Angela Losi et al. (2017). Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network). (ekstern lenke)
• K Wachtell; G Smith; Eva Gerdts et al. (2000). Left ventricular diastolic filling patterns in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. (ekstern lenke)
• Anders M. Greve; Eva Gerdts; Kurt Boman et al. (2011). Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data). (ekstern lenke)
• Dana Cramariuc; Eva Gerdts; Johannes Just Hjertaas et al. (2015). Myocardial function in aortic stenosis - insights from radial multilayer Doppler strain. (ekstern lenke)
• Peter M. Okin; Eva Gerdts; Kristiana Wachtell et al. (2010). Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation. (ekstern lenke)
• Giovanni Cioffi; Dana Cramariuc; Morten Dalsgaard et al. (2011). Left atrial systolic force in asymptomatic ortic stenosis. (ekstern lenke)
• V. Papademetriou; R. B. Devereux; P. Narayan et al. (2001). Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE Study. (ekstern lenke)
• Henrik K. Thomassen; Giovanni Cioffi; Eva Gerdts et al. (2017). Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis. (ekstern lenke)
• Eva Gerdts; JE Otterstad (2000). HOPE ett år senere. (ekstern lenke)
• Morten Dalsgaard; Kenneth Egstrup; Kristian Wachtell et al. (2008). Left atrial volume in patients with asymptomatic aortic valve stenosis (the simvastatin and ezetimibe in aortic stenosis study). (ekstern lenke)
• K Wachtell; B Hornestam; M Lehto et al. (2005). Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. (ekstern lenke)
• Kristiana Wachtell; Eva Gerdts; Gerard P. Aurigemma et al. (2010). In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. (ekstern lenke)
• K Wachtell; M Lehto; E Gerdts et al. (2005). Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. (ekstern lenke)
• Eva Gerdts; Dana Cramariuc; Giovanni de Simone et al. (2008). Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). (ekstern lenke)
• Vittorio Palmieri; Peter M. Okin; Jonathan N. Bella et al. (2003). Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiograaphhic left ventricular hypertrophy The life study. (ekstern lenke)
• Silvana Cicala; Richard B. Devereux; Giovanni de Simone et al. (2007). Electrocardiographic and echocardiographic detection of myocardial infarction in patients with left-ventricular hypertrophy. (ekstern lenke)
• Eva Gerdts; Per Omvik; Rune Mo et al. (2004). Hypertensjon og hjertesykdom. (ekstern lenke)
• Stian Ludvigsen; Costantino Mancusi; Simon Kildal et al. (2018). Cardiac adaptation to hypertension in adult female Dahl salt-sensitive rats is dependent on ovarian function, but loss of ovarian function does not predict early maladaptation. (ekstern lenke)
• E.M. Staal; Ottar Nygård; Per Omvik et al. (2004). Blood pressure measurements by the Keito machine. Evaluation versus office blood pressure by physicians. (ekstern lenke)
• M.H. Olsen; K. Wachtell; J.N. Bella et al. (2004). Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy). (ekstern lenke)
• Ingrid Os; Veronica Franco; Sverre E. Kjeldsen et al. (2008). Effects of Losartan in women with hypertension and left ventricular hypertrophy results from the Losartan Intervention For Endpoint Reduction in hypertension study. (ekstern lenke)
• Bernd Timmermann; Rune Mo; Friederich C Luft et al. (1998). Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. (ekstern lenke)
• Eva Gerdts; Einar Svarstad; Ole Langeland Myking et al. (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus. (ekstern lenke)
• Eva Gerdts; Per Omvik; Per Lund-Johansen (1999). Reproducibility of salt sensitivity testing using a dictary approach in essential hypertension. (ekstern lenke)
• Grzegorz Piotrowski; Maciej Banach; Eva Gerdts et al. (2011). Left atrial size in hypertension and stroke. (ekstern lenke)
• Eva Gerdts; Hans Bjørnstad; Richard B. Devereux et al. (2006). Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). (ekstern lenke)
• Lene Vernås Halvorsen; Camilla Lund Søraas; Anne Cecilie Kjeldsen Larstorp et al. (2024). Effect of Therapeutic Drug Monitoring on Adherence and Blood Pressure: A Multicenter Randomized Clinical Trial. (ekstern lenke)
• Giovanni Cioffi; Dana Cramariuc; Morten Dalsgaard et al. (2012). Left Atrial Systolic Force and Outcome in Asymptomatic Mild to Moderate Aortic Stenosis. (ekstern lenke)
• Per Omvik; Eva Gerdts; Ole L. Myking et al. (2000). Long-term central hemodynamic effects at rest and during exercise of losartan in essential hypertension. (ekstern lenke)
• Kristian Wachtell; Jonathan N. Bella; Jens Rokkedal et al. (2002). Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. (ekstern lenke)
• Einar Skulstad Davidsen; Knut Liseth; Per Omvik et al. (2007). Reduced exercise capacity in genetic haemochromatosis. (ekstern lenke)
• Silvia Damiano; Marina De Marco; Federica del Genio et al. (2012). Effect of bariatric surgery on left ventricular geometry and function in severe obesity. (ekstern lenke)
• Morten Dalsgaard; Kenneth Egstrup; Kristian Wachtell et al. (2013). Left atrial volume as predictor of valve replacement and cardiovascular events in patients with asymptomatic mild to moderate aortic stenosis. (ekstern lenke)
• Costantino Mancusi; Eva Gerdts; Giovanni de Simone et al. (2014). Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study). (ekstern lenke)
• Nicolas Martinez-Majander; Shakar Kutal; Pauli Ylikotila et al. (2024). Association between heavy alcohol consumption and cryptogenic ischaemic stroke in young adults: A case-control study. (ekstern lenke)
• Eva Gerdts; Ole Langeland Myking; Per Lund-Johansen et al. (1996). Factors influencing left ventricular mass in hypertensive type-1 diabetic patients. (ekstern lenke)
• Pilly Mussa Chillo; johnson lwakatare; Janet Joy Kachuchuru Lutale et al. (2012). Increased relative wall thickness is a marker of subclinical cardiac target-organ damage in African diabetic patients. (ekstern lenke)
• Eva Gerdts; Giovanni de Simone (2021). Hypertension in women: Should there be a sex-specific threshold?. (ekstern lenke)
• Helga Bergljot Midtbø; Ester Anne Kringeland; Eva Gerdts et al. (2022). Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab. (ekstern lenke)
• Alexander Lilja-Cyron; Casper N. Bang; Eva Gerdts et al. (2022). Aortic root dilatation in hypertensive patients with left ventricular hypertrophy–application of a new multivariate predictive model. The Life Study. (ekstern lenke)
• Katrine Tryti Lindseth; Eva Gerdts; Helga Bergljot Midtbø et al. (2023). Myocardial Work in Middle-Aged Adults with Overweight and Obesity: Associations with Sex and Central Arterial Stiffness. (ekstern lenke)
• Helga Bergljot Midtbø; Eva Gerdts; Inger Jorid Berg et al. (2018). Ankylosing spondylitis is associated with increased prevalence of left ventricular hypertrophy. (ekstern lenke)
• Einar Skulstad Davidsen; Tor Hervig; Per Omvik et al. (2009). Left ventricular long-axis function in treated haemochromatosis. (ekstern lenke)
• Kristian Wachtell; Vittorio Palmieri; Eva Gerdts et al. (2010). Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study). (ekstern lenke)
• Bertina Nielsen Herfindal; Eva Gerdts; Ester Anne Kringeland et al. (2020). Concomitant hypertension is associated with abnormal left ventricular geometry and lower systolic myocardial function in overweight participants: the FAT associated CardiOvasculaR dysfunction study. (ekstern lenke)
• Anne B. Rossebø; Terje R. Pedersen; Christopher Allen et al. (2007). Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. (ekstern lenke)
• Lucas Lauder; Thomas Weber; Michael Böhm et al. (2025). European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice. (ekstern lenke)
• Costantino Mancusi; Maria Angela Losi; Raffaele Izzo et al. (2019). Prognostic impact of increased pulse pressure/stroke index in a registry of hypertensive patients: the Campania Salute Network. (ekstern lenke)
• Rune Krogh Eilertsen; Helga Bergljot Midtbø; Rasmus Bach Sindre et al. (2024). Factors associated with progression of arterial stiffness in ischemic stroke survivors: the Norwegian Stroke in the Young Study. (ekstern lenke)
• Vera Regitz-Zagrosek; Sabine Oertelt-Prigione; Eva Prescott et al. (2016). Gender in cardiovascular diseases: Impact on clinical manifestations, management, and outcomes. (ekstern lenke)
• Helga Bergljot Midtbø; Eva Gerdts; Tore Kristian Kvien et al. (2016). The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis. (ekstern lenke)
• Ola Undrum Bergland; Lene Vernås Halvorsen; Camilla Lund Søraas et al. (2021). Detection of Nonadherence to Antihypertensive Treatment by Measurements of Serum Drug Concentrations. (ekstern lenke)
• Bin Zhou; Mariachiara Di Cesare; Carlos A Aguilar-Salinas et al. (2024). General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants. (ekstern lenke)
• Hager Rahmatalla Zein Elabdeen; Ellen Berggreen; Knut Helge Jensen et al. (2025). Prevalence of Periodontitis in a 70-Year-Old Population in Western Norway According to the ACES 2018 Classification Framework: A Cross-Sectional Study. (ekstern lenke)
• K Wachtell; JN Bella; PR Liebson et al. (2000). Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE Study. (ekstern lenke)
• Eva Gerdts; M. Zabalgoitia; H. Björnstad et al. (2001). Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). (ekstern lenke)
• Mai Tone Lønnebakken; Eva Gerdts; Kurt Boman et al. (2011). In-treatment stroke volume predicts cardiovascular risk in hypertension. (ekstern lenke)
• Eva Gerdts; Kristian Wachtell; Per Omvik et al. (2007). Left atrial size and risk of major cardiovascular events during antihypertensive treatment - Losartan intervention for endpoint reduction in hypertension trial. (ekstern lenke)
• K Wachtell; G Smith; Eva Gerdts et al. (2000). Left ventricular diastolic filling patterns in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. (ekstern lenke)
• Sahrai Saeed; Ulrike Waje-Andreassen; Annette Fromm et al. (2014). Early vascular aging in young and middle-aged ischemic stroke patients: The Norwegian stroke in the young study. (ekstern lenke)
• T Melberg; Karel Kuiper; Eva Gerdts et al. (1999). Early complications and long-term mortality after urgent or routine coronary angioplasty. (ekstern lenke)
• Arleen Aune; Marina Victorovna Kokorina; Marianne Aa. Grytaas et al. (2021). Preclinical cardiac disease in women and men with primary aldosteronism. (ekstern lenke)
• Gerard P Aurigemma; Richard B. Devereux; Kristian Wachtell et al. (2003). Left ventricular mass regression in the life study: effect of previous antihypertensive treatment. (ekstern lenke)
• Einar S Davidsen; Eva Gerdts (2003). Hjertesykdom ved genetisk hemokromatose. (ekstern lenke)
• Sahrai Saeed; Eva Gerdts; Ulrike Waje-Andreassen et al. (2019). Searching for explanations for cryptogenic stroke in the young: Revealing the Etiology, Triggers, and outcome (SECRETO): Echocardiography performance protocol. (ekstern lenke)
• R.B. Devereux; K. Wachtell; Eva Gerdts et al. (2004). Prognostic significance of left ventricular mass change during treatment of hypertension. (ekstern lenke)
• J. Kontos; V. Papademetriou; K. Wachtell et al. (2004). Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study. (ekstern lenke)
• Edda Bahlmann; Dana Cramariuc; Sahrai Saeed et al. (2019). Low systemic arterial compliance is associated with increased cardiovascular morbidity and mortality in aortic valve stenosis. (ekstern lenke)
• Eva Gerdts; M.J. Roman; V. Palmieri et al. (2004). Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study). (ekstern lenke)
• Dana Cramariuc; Eva Gerdts; Einar Skulstad Davidsen et al. (2010). Myocardial deformation in aortic valve stenosis – relation to left ventricular geometry. (ekstern lenke)
• Marcus Lund Frølich; Einar Skulstad Davidsen; Mai Tone Lønnebakken et al. (2010). An unusual location of a papillary fibroelastoma. (ekstern lenke)
• Eva Gerdts; Peter M. Okin; Giovanni de Simone et al. (2008). Gender differences in left ventricular structure and function during antihypertensive treatment - The Losartan intervention for Endpoint reduction in hypertension study. (ekstern lenke)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (1998). Factors Influencing Left Ventricular Mass in Salt Sensitive and Salt Resistant Essential Hypertensive Patients. (ekstern lenke)
• Anders M. Greve; Michael Hecht Olsen; Jonathan N. Bella et al. (2012). Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: A LIFE study. (ekstern lenke)
• Edda Bahlmann; Dana Cramariuc; Jan Minners et al. (2017). Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implications. (ekstern lenke)
• Anne B. Rossebø; AB Rossebo; Terje R. Pedersen et al. (2008). Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. (ekstern lenke)
• Eva Gerdts; Gunnar Kvam; R Mo et al. (1998). The Bergen Blood pressure Study: changes in cardiac structure and function in offspring of hypertensive families. (ekstern lenke)
• Eva Gerdts; Z Zabalgoitia; H Bjornstad et al. (1998). Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy. The LIFE. (ekstern lenke)
• Mai Tone Lønnebakken; Marianne Staal; Øyvind Bleie et al. (2009). Quantitative contrast stress echocardiography in assessment of restenosis after percutaneous coronary intervention in stable coronary artery disease. (ekstern lenke)
• Giovanni de Simone; Peter M. Okin; Eva Gerdts et al. (2009). Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. (ekstern lenke)
• Marcello Chinali; Gerard P Aurigemma; Giovanni de Simone et al. (2009). Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients During Antihypertensive Treatment (from the LIFE Echo-Substudy). (ekstern lenke)
• Giovanni Cioffi; Tiziano Edoardo Russo; Carlo Stefenelli et al. (2010). Severe obstructive sleep apnea elicits concentric left ventricular geometry. (ekstern lenke)
• Nikolaus Jander; Jan Minners; Ingar Morten K Holme et al. (2011). Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. (ekstern lenke)
• Sahrai Saeed; Roxy Senior; Navtej S. Chahal et al. (2017). Lower transaortic flow rate is Associated with increased mortality in aortic valve stenosis. (ekstern lenke)
• Giovanni Cioffi; Eva Gerdts; Dana Cramariuc et al. (2010). Left atrial size and force in patients with systolic chronic heart failure: Comparison with healthy controls and different cardiac diseases. (ekstern lenke)
• Jannike Øyen; Anne Lise Brantsæter; Lene Secher Myrmel et al. (2025). Maternal intake of dietary protein from plant and animal sources and development of pharmacologically treated hypertension within 10 years after pregnancy. (ekstern lenke)
• Anders M. Greve; Eva Gerdts; Kurt Boman et al. (2012). Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis the SEAS (Simvastatin and Ezetimibe in aortic stenosis) study. (ekstern lenke)
• Janet Joy Kachuchuru Lutale; Hrafnkell Thordarson; Zulfiqarali Gulam-Abbas et al. (2008). Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania. (ekstern lenke)
• Eigir Einarsen; Sahrai Saeed; Dana Cramariuc et al. (2019). Impact of obesity on persistent left Ventricular hypertrophy after aortic valve replacement for aortic stenosis. (ekstern lenke)
• Kristian Wachtell; Vittorio Palmieri; Michael Hecht Olsen et al. (2002). Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study. (ekstern lenke)
• Barbara Rogge; Eva Gerdts; Dana Cramariuc et al. (2014). Impact of obesity and nonobesity on grading the severity of aortic valve stenosis. (ekstern lenke)
• Annabel Eide Ohldieck; Ester Anne Kringeland; Helga Bergljot Midtbø et al. (2023). High-normal blood pressure in midlife is a stronger risk factor for incident hypertension 26 years later in women than men: the Hordaland Health Study. (ekstern lenke)
• Costantino Mancusi; Helga Bergljot Midtbø; Nicola De Luca et al. (2021). Association of myocardial energetic efficiency with circumferential and longitudinal left ventricular myocardial function in subjects with increased body mass index (The fatcor study). (ekstern lenke)
• Marina De Marco; Eva Gerdts; Costantino Mancusi et al. (2017). Influence of left ventricular stroke volume on incident heart failure in a population with preserved ejection fraction (from the Strong Heart Study). (ekstern lenke)
• G De Simone; PM Okin; E Gerdts et al. (2009). Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. (ekstern lenke)
• Christa Gohlke-Bärwolf; Jan Minners; Nicolaus Jander et al. (2013). Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study. (ekstern lenke)
• Ester Anne Kringeland; Eva Gerdts; Arve Ulvik et al. (2022). Inflammation, sex, blood pressure changes and hypertension in midlife: the Hordaland Health Study. (ekstern lenke)
• Casper N. Bang; Eva Gerdts; Gerard P. Aurigemma et al. (2013). Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study. (ekstern lenke)
• Dana Cramariuc; Giovanni Cioffi; Åshild Elseth Rieck et al. (2009). Low-Flow Aortic Stenosis in Asymptomatic Patients Valvular-Arterial Impedance and Systolic Function From the SEAS Substudy. (ekstern lenke)
• Isabel Eva Kenny; Sahrai Saeed; Eva Gerdts et al. (2017). Masked hypertension in obesity: Potential predictors and arterial damage. (ekstern lenke)
• Kurt Boman; Eva Gerdts; Kristian Wachtell et al. (2009). Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study. (ekstern lenke)
• Shakar Kutal; Lauri Juhani Tulkki; Tomi Sarkanen et al. (2025). Association Between Self-Perceived Stress and Cryptogenic Ischemic Stroke in Young Adults: A Case-Control Study. (ekstern lenke)
• Eva Gerdts; Ole Myking; Per Lund-Johansen et al. (1997). Factors influencing LVM in hypertensitive type-1 diabetic patients. (ekstern lenke)
• Eva Gerdts; Einar Svarstad; Sylvi Aanderud et al. (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for months months. (ekstern lenke)
• Silvana Cicala; Giovanni de Simone; Kristian Wachtell et al. (2008). Clinical impact of ' in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study. (ekstern lenke)
• Maria-Angela Losi; Costantino Mancusi; Helga Bergljot Midtbø et al. (2019). Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis. (ekstern lenke)
• Lisa Marie Dale Grymyr; Saied Nadirpour; Eva Gerdts et al. (2025). Long-Term Trajectories of Left Heart Geometry, Mechanics, and Oxygen Demand After Bariatric Surgery. (ekstern lenke)
• Giovanni Cioffi; Pompilio Faggiano; Enrico Vizzardi et al. (2011). Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. (ekstern lenke)
• Rune Krogh Eilertsen; Helga Bergljot Midtbø; Beenish Adeel Chaudry Nawaz et al. (2025). Associations of short-term blood pressure variability with presence and progression of organ damage over five years in ischaemic stroke survivors: the Norwegian Stroke in the Young Study. (ekstern lenke)
• Sahrai Saeed; Ulrike Waje-Andreassen; Mai Tone Lønnebakken et al. (2016). Covariates of non-dipping and elevated night-time blood pressure in ischemic stroke patients: the Norwegian Stroke in the Young Study. (ekstern lenke)
• Sahrai Saeed; Eva Gerdts; Ulrike Waje-Andreassen et al. (2019). Left ventricular myocardial dysfunction in young and middle-aged ischemic stroke patients: the Norwegian stroke in the young study. (ekstern lenke)
• Giovanni Cioffi; Giovanni de Simone; Dana Cramariuc et al. (2012). Inappropriately high left-ventricular mass in asymptomatic mild-moderate aortic stenosis. (ekstern lenke)
• Silvana Cicala; Giovanni de Simone; Eva Gerdts et al. (2010). Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study. (ekstern lenke)
• Peter M. Okin; Kristian Wachtell; Eva Gerdts et al. (2014). Relationship of levt ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the Development of New heart failure. (ekstern lenke)
• Mai Tone Lønnebakken; Terje H Larsen; Eva Gerdts et al. (2014). Iatrogenic external pudendal artery pseudoaneurysm with a communicating arteriovenous fistula - A diagnostic and therapeutic pitfall. (ekstern lenke)
• Eva Gerdts; Einar Svarstad; Ole Landmark Myking et al. (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus. (ekstern lenke)
• Anders M. Greve; Eva Gerdts; Kurt Boman et al. (2013). Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study. (ekstern lenke)
• Åshild Elseth Rieck; Eva Gerdts; Mai Tone Lønnebakken et al. (2012). Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial). (ekstern lenke)
• PM Okin; E Gerdts; Sverre Erik Kjeldsen et al. (2008). Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy in Response to Antihypertensive Therapy. (ekstern lenke)
• Eva Gerdts; JE Otterstad (2000). HOPE ett år senere. (ekstern lenke)
• Peter M. Okin; Richard B. Devereux; Eva Gerdts et al. (2006). Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy - The Losartan Intervention for Endpoint (LIFE) Reduction in Hypertension Study. (ekstern lenke)
• Per Omvik; Eva Gerdts; O Myking et al. (1999). Similar central hemodynamics in salt sensitive and salt resistant hypertensive patients. (ekstern lenke)
• J. N. Bella; K. Wachtell; V. Palmieri et al. (2001). Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. (ekstern lenke)
• Nikolaus Jander; Christa Gohlke-Bärwolf; Edda Bahlmann et al. (2014). Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis. (ekstern lenke)
• Eva Gerdts; Einar Svarstad; Sylvi Aanderud et al. (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using Captopril or Doxazosin for months. (ekstern lenke)
• Edda Bahlmann; Christoph A. Nienaber; Dana Cramariuc et al. (2011). Aortic root geometry in aortic stenosis patients (a SEAS substudy). (ekstern lenke)
• R.B. Devereux; B. Dahlof; Eva Gerdts et al. (2004). Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol - The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. (ekstern lenke)
• Eva Gerdts; Ole L. Myking; Per Omvik (1994). Salt sensitive essential hyperdension evaluated by 24 hour ambulatory blood pressure. (ekstern lenke)
• Hilde Espnes; Tom Wilsgaard; Jocasta Ball et al. (2025). Heart Failure in Atrial Fibrillation Subtypes in Women and Men in the Tromsø Study. (ekstern lenke)
• Z.B. Li; K. Wachtell; P.M. Okin et al. (2004). Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study. (ekstern lenke)
• Lisa Marie Dale Grymyr; Saied Nadirpour; Eva Gerdts et al. (2021). One-year impact of bariatric surgery on left ventricular mechanics: results from the prospective FatWest study. (ekstern lenke)
• Joshua B Feinberg; Emil E Nielsen; Sverre Kjeldsen et al. (2023). Sex Differences in Atrial Fibrillation and Associated Complications in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study. (ekstern lenke)
• Anja Linde; Eva Gerdts; Bjørg Tilde Svanes Fevang et al. (2024). Factors associated with change in arterial stiffness in patients with rheumatoid arthritis: the JointHeart study. (ekstern lenke)
• Cedric Davidsen; Terje H Larsen; Eva Gerdts et al. (2016). Giant right ventricular outflow tract thrombus in heriditary spherocytosis: a case report. (ekstern lenke)
• Nadia Pristaj; Sahrai Saeed; Helga Bergljot Midtbø et al. (2020). Covariables of myocardial function in women and men with increased body mass index. (ekstern lenke)
• Eva Gerdts; Sahrai Saeed; Helga Bergljot Midtbø et al. (2019). Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis. (ekstern lenke)
• Mari Bergflødt Sørensen; Hanne Rosendahl-Riise; Kristin Øksendal Børresen et al. (2025). Low maternal iodine intake and subsequent risk of pharmacologically treated hypertension: A population-based prospective cohort study. (ekstern lenke)
• Mai Tone Lønnebakken; Raffaele Izzo; Costantino Mancusi et al. (2017). Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania salute network). (ekstern lenke)
• Anja G Linde; Eva Gerdts; Kåre Steinar Tveit et al. (2021). Subclinical cardiac organ damage in patients with moderate to severe psoriasis. (ekstern lenke)
• Annabel Eide Ohldieck; Helga Bergljot Midtbø; Ester Anne Kringeland et al. (2025). Stronger Association Between Blood Pressure and Arterial Stiffness in Older Women than Men: The Hordaland Health Study. (ekstern lenke)
• Åshild E.Eidheim Elseth Rieck; Dana Cramariuc; Eva Marianne Staal et al. (2010). Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy). (ekstern lenke)
• Dana Cramariuc; Giovanni Cioffi; Åshild E.Eidheim Elseth Rieck et al. (2009). Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. (ekstern lenke)
• Gyda Ullensvang; Ester Anne Kringeland; Eirik Ikdahl et al. (2023). Cardiovascular organ damage in relation to hypertension status in patients with ankylosing spondylitis. (ekstern lenke)
• Edda Bahlmann; Eigir Einarsen; Dana Cramariuc et al. (2022). Prognosis in asymptomatic patients with discordantly graded aortic valve stenosis based on pressure recovery adjusted valve area. (ekstern lenke)
• Dana Cramariuc; Åshild E.Eidheim Elseth Rieck; Eva Marianne Staal et al. (2008). Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS substudy). (ekstern lenke)
• Nicolaus Jander; Willibald Hochholzer; Beat A. Kaufmann et al. (2014). Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF. (ekstern lenke)
• Ingar Morten K Holme; Terje Rolf Pedersen; Kurt Boman et al. (2012). A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis. (ekstern lenke)
• Mai Tone Lønnebakken; Costantino Mancusi; Mari Angela Losi et al. (2019). Weight loss facilitates reduction of left ventricular mass in obese hypertensive patients: The Campania Salute Network. (ekstern lenke)
• Eva Gerdts (2002). Bruk av ekkokardiografi i hypertensjonsstudier. (ekstern lenke)
• Kristian Wachtell; Vittorio Palmieri; Michael Hecht Olsen et al. (2002). Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. (ekstern lenke)
• Eva Gerdts; Vasilios Papademetriou; Vittorio Palmieri et al. (2002). Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). (ekstern lenke)
• Ester Anne Kringeland; Grethe S. Tell; Helga Bergljot Midtbø et al. (2021). Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study. (ekstern lenke)
• Anja G Linde; Eva Gerdts; Ulrike Waje-Andreassen et al. (2018). Covariables and types of abnormal left ventricular geometry in nonelderly ischemic stroke survivors: The Norwegian Stroke in theYoung Study. (ekstern lenke)
• Gianfranco Parati; Alexandra Goncalves; David Soergel et al. (2023). New perspectives for hypertension management: progress in methodological and technological developments. (ekstern lenke)
• Nina Kovac; Lisa Marie Dale Grymyr; Eva Gerdts et al. (2022). Markers of Subclinical Atherosclerosis in Severe Obesity and One Year after Bariatric Surgery. (ekstern lenke)
• Ingeborg Eskerud; Eva Gerdts; Terje Hjalmar Larsen et al. (2021). Total coronary atherosclerotic plaque burden is associated with myocardial ischemia in non-obstructive coronary artery disease. (ekstern lenke)
• Ester Anne Kringeland; Grethe S. Tell; Helga Bergljot Midtbø et al. (2020). Factors associated with increase in blood pressure and incident hypertension in early midlife: the Hordaland Health Study. (ekstern lenke)
• Sergej Ostojic; Nowell H. Phelps; Rosie K. Singleton et al. (2024). Worldwide trends in the underweight and obesity from 1990 to 2022: a pooled analysis of 3,633 population-representative studies with 222 million school-aged children, adolescents, and adults. (ekstern lenke)
• Nora Tuseth; Dana Cramariuc; Åshild E.Eidheim Elseth Rieck et al. (2010). Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy). (ekstern lenke)
• Sahrai Saeed; Ulrike Waje-Andreassen; Annette Fromm et al. (2016). Prevalence and covariates of masked hypertension in ischemic stroke survivors: the Norwegian Stroke in the Young Study.. (ekstern lenke)
• Eva Gerdts; Peter M. Okin; Per Omvik et al. (2009). Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study. (ekstern lenke)
• Helga Bergljot Midtbø; Arve Ulvik; Dana Cramariuc et al. (2024). Influence of cardiorespiratory fitness on obesity-associated inflammation in women and men: The FATCOR study. (ekstern lenke)
• Lisa Marie Dale Grymyr; Gunnar Mellgren; Adrian McCann et al. (2024). Preoperative risk factors associated with left ventricular dysfunction after bariatric surgery. (ekstern lenke)
• Eigir Einarsen; Johannes Just Hjertaas; Haotian Gu et al. (2021). Impact of arterio-ventricular interaction on first-phase ejection fraction in aortic stenosis. (ekstern lenke)
• Eva Gerdts; O. L. Myking; Per Lund-Johansen et al. (1997). Regression of left ventricular hypertrophy in type-1 diabetic patients using doxazosin as antihypertensive therapy @<abstract@>. (ekstern lenke)
• Einar Svarstad; Eva Gerdts; Per Omvik et al. (2001). Renal hemodynamic effects of captopril and doxazosin during slight physical activity in hypertensive patients with type-1 diabetes mellitus. (ekstern lenke)
• Edda Bahlmann; Dana Cramariuc; Eva Gerdts et al. (2010). Impact of Pressure Recovery on Echocardiographic Assessment of Asymptomatic Aortic Stenosis: A SEAS Substudy. (ekstern lenke)
• Marcello Chinali; Giovanni de Simone; Kristian Wachtell et al. (2008). Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study. (ekstern lenke)
• Asle Hirth; Nicola C. Edwards; Gottfried Greve et al. (2012). Left ventricular function in children and adults after renal transplantation in childhood. (ekstern lenke)
• Mai Tone Lønnebakken; Ingeborg Eskerud; Terje H Larsen et al. (2019). Impact of aortic stiffness on myocardial ischaemia in non-obstructive coronary artery disease. (ekstern lenke)
• Helga Bergljot Midtbø; Anne Grete Semb; Knut Matre et al. (2016). Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis. (ekstern lenke)
• Eva Gerdts; E. Svarstad; Sylvi Aanderud et al. (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using Captopril or Doxazosin for months. (ekstern lenke)
• Eran S. Zacks; Ildri Maria Stokke; Kristian Wachtell et al. (2022). Time-varying serum uric acid predicts new-onset atrial fibrillation in treated hypertensive patients. The LIFE Study. (ekstern lenke)

Annen presentasjon

• Leonora Onarheim Bergsjø; Eva Gerdts; Tone Merete Norekvål (2025). Hjertehelse er ikke kjønnsnøytralt - kan e-helse bli det?. (ekstern lenke)

Vitenskapelig bokkapittel

• Eva Gerdts (1994). Hjertesykdom og svangerskap. (ekstern lenke)

Konferanseabstrakt

• Peter M. Okin; Kristian Wachtell; Eva Gerdts et al. (2007). Relationship of left ventricular Systolic function to persistence or development,of Electrocardiographic left ventricular hypertrophy in hypertensive patients: Implications for the development of new heart failure. (ekstern lenke)
• AE Rieck; Dana Cramariuc; Eva M Staal et al. (2009). ISOLATED SYSTOLIC HYPERTENSION IN PATIENTS WITH ASYMPTOMATIC AORTIC STENOSIS (A SEAS SUBSTUDY). (ekstern lenke)
• I Eskerud; Eva Gerdts; Jan Erik Nordrehaug et al. (2013). Coronary artery plaque burden is a predictor of myocardial ischemia in non-ST elevation myocardial infarction in both genders. (ekstern lenke)
• Sverre Kjeldsen; Eran S. Zachs; Ildri Maria Stokke et al. (2022). Time-varying serum uric acid predicts new-onset atrial fibrillation in treated hypersensitive patients. (ekstern lenke)
• Peter M. Okin; Eva Gerdts; Kristian Wachtell et al. (2006). Relationship of left atrial enlargement to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation. (ekstern lenke)
• Einar Skulstad Davidsen; Karel Kier-Jan Kuiper; Knut Matre et al. (2014). Determinants of left ventricular systolic function after transcatheter aortic valve implantation. (ekstern lenke)
• V. Palmieri; PM Okin; K. Wachtell et al. (2005). Relationship of electrocardiographic strain pattern to left ventricular diastolic function in hypertensive patients: The LIFE study. (ekstern lenke)
• A Rossebo; Christa Gohlke-Bärwolf; K Boman et al. (2010). Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study). (ekstern lenke)
• D Cramariuc; MT Lonnebakken; C Gohlke-Barwolf et al. (2012). Midwall left ventricular systolic function in asymptomatic aortic valve stenosis: is it prognostically important? The SEAS study. (ekstern lenke)
• Eva Gerdts; I Botta; G Cioffi et al. (2012). Covariates of global longitudinal strain and displacement in type 2 diabetes: a speckle tracking echocardiography study. (ekstern lenke)
• Giovanni de Simone; Peter M. Okin; Eva Gerdts et al. (2007). Does metabolic syndrome influence reduction of ECG left ventricular hypertrophy? The LIFE study. (ekstern lenke)
• P. Chillo; J. Lwakatare; Janet Joy Kachuchuru Lutale et al. (2010). Increased Relative Wall Thickness - A Frequent Marker of Subclinical Cardiac Target Organ Damage in African Diabetic Patients. (ekstern lenke)
• E.S. Davidsen; Eva Gerdts (2004). Tissue Doppler findings in patients with genetic hemochromatosis. (ekstern lenke)
• Dana Cramariuc; Åshild E.Eidheim Elseth Rieck; Eva Staal et al. (2007). Impact of left ventricular geometry on stress-corrected left ventricular systolic function in asymptomatic aortic valve stenosis. A SEAS substudy. (ekstern lenke)
• M. Chinalli; G. Simone; J.M. Gardin et al. (2004). Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: The LIFE Study. (ekstern lenke)
• H Midtbo; Eva Gerdts; IC Olsen et al. (2013). Disease Activity In Rheumatoid Arthritis Is Associated With Abnormal Left Ventricular Geometry. (ekstern lenke)
• Dana Cramariuc; Åshild Elseth Rieck; Giovanni Cioffi et al. (2011). Impact of valvuloarterial impedance on cardiovascular outcome in patients with asymptomatic aortic stenosis. The SEAS study. (ekstern lenke)
• Eva Gerdts; E Gerdts; IC Olsen et al. (2013). Arterial Stiffness Is Associated With Abnormal Left Ventricular Geometry In Patients With Rheumatoid Arthritis. (ekstern lenke)
• Mai Tone Lønnebakken; Jan Erik Nordrehaug; Eva Marianne Staal et al. (2010). Hypoperfusion by contrast echocardiography predicts coronary artery disease severity in non-ST elevation myocardial infarction. (ekstern lenke)
• Dana Cramariuc; Giovanni Ciotti; Åshild E.Eidheim Elseth Rieck et al. (2008). Impact of global afterload on left ventricular myocardial contractility in asymptomatic aortic stenosis: A SEAS substudy. (ekstern lenke)
• Ekaterina Sharashova; Tom Wilsgaard; Inger Njølstad et al. (2018). 6168 Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study. (ekstern lenke)
• Eva Gerdts; Dana Cramariuc; Åshild E.Eidheim Elseth Rieck et al. (2007). Pulse pressure - An independent predictor of left ventricular hyperthrophy in patients with asymptomatic aortic stenosis. A SEAS substudy. (ekstern lenke)
• Raffaele Izzo; Giovanni de Simone; Valentina Trimarco et al. (2013). Hypertensive target organ damage predicts incident diabetes mellitus. (ekstern lenke)
• Marcello Chinali; Rakesh K. Mishra; Giovanni de Simone et al. (2007). Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during anti-hypertensive treatment: The LIFE echo-substudy. (ekstern lenke)
• Dana Cramariuc; Johannes Just Hjertaas; Leidulf Segadal et al. (2011). Impact of aortic valve stenosis and hypertension on radial strain in multiple layers. (ekstern lenke)
• Mai Tone Lønnebakken; Eva Gerdts; K Boman et al. (2009). IMPACT OF STROKE VOLUME ON CARDIOVASCULAR RISK IN HYPERTENSIVE PATIENTS WITH ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY (A LIFE SUBSTUDY). (ekstern lenke)
• Dana Cramariuc; Eva Gerdts; Einar Skulstad Davidsen et al. (2008). The differential impact of static and pulsatile blood pressure components on regional myocardial deformation in patients with asymptomatic aortic valve stenosis. A SEAS substudy. (ekstern lenke)
• Zoya Sabir; Jutta Dierkes; Anette Hjartåker et al. (2023). Dietary Intake And Adherence To Food-Based Dietary Guidelines In Older Norwegian Adults – The Hordaland Health Studies. (ekstern lenke)
• K. Wachtell; V. Palmieri; Eva Gerdts et al. (2004). Myocardial performance index independently predicts cardiovascular morbidity and mortality in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. (ekstern lenke)
• Eva M Staal; Ottar K Nygard; Per Omvik et al. (2005). Influence of hypertension on angiographic findings in patients with angina pectoris. (ekstern lenke)
• Edda Bahlmann; Dana Cramariuc; Eva Gerdts et al. (2008). Impact of Pressure Recovery on Diagnosis of Severe Aortic Stenosis In Asymptomatic Patients. (A SEAS Substudy). (ekstern lenke)
• Ekaterina Sharashova; Tom Wilsgaard; Jocasta Ball et al. (2020). Sex-specific temporal trends in the incidence of atrial fibrillation in a large Norwegian population-based study 1986–2014. (ekstern lenke)
• Zhibin Li; Kristian Wachtell; Sverre E. Kjeldsen et al. (2007). Association of aortic regurgitation with cardiovascular morbidity and mortality in hypertensive patients with left ventricle hypertrophy: The LIFE study. (ekstern lenke)
• Dana Cramariuc; Giovanni Cioffi; Christa Golke-Bärwolf et al. (2009). Relation of degree of aortic valve calcification to left ventricular geometry and systolic function in asymptomatic aortic valve stenosis: A SEAS substudy. (ekstern lenke)
• Dana Cramariuc; Eva Gerdts; Einar Skulstad Davidsen et al. (2009). 2D Longitudinal Myocardial Strain: A More Sensitive Parameter of Left Ventricular Dysfunction in Aortic Valve Stenosis?. (ekstern lenke)
• Jan Minners; Nikolaus Jander; Eva Gerdts et al. (2013). Outcome in 1763 asymptomatic patients with mild or moderate calcific aortic stenosis followed prospectively with annual echocardiography. (ekstern lenke)
• Eva Gerdts; Dana Cramariuc; Mai Tone Lønnebakken et al. (2010). Left ventricular mass, an independent predictor of morbidity and mortality in aortic valve stenosis. (ekstern lenke)
• Dana Cramariuc; Åshild E.Eidheim Elseth Rieck; Eva Marianne Staal et al. (2006). Prevalence and covariates of low left ventricular midwall shortening in patients with asymptomatic aortic valve stenosis. A SEAS substudy. (ekstern lenke)
• N Jander; J Minners; I Holme et al. (2009). Outcome of Asymptomatic Patients With Low Gradient "Severe" Aortic Valve Stenosis and Preserved Ejection Fraction - Results From the Prospective SEAS Study. (ekstern lenke)
• R.B. Devereux; K. Wachtell; Eva Gerdts et al. (2004). Ethnicity, left ventricular hypertrophy regressio and cardiovascular events in the LIFE echocardiography substudy. (ekstern lenke)
• S. Donkor; S. Gordon; Per Omvik et al. (2004). Blood pressure and cardiovascular risk factors in hypertensive patients referred to a regional hospital in Ghana. (ekstern lenke)
• K. Wachtell; V. Palmieri; Eva Gerdts et al. (2005). Echocardiographic determinants of new-onset atrial fibrillation in patients with hypertension and electrocardiographic left ventricular hypertrophy: The LIFE study. (ekstern lenke)
• Dana Cramariuc; Åshild E.Eidheim Elseth Rieck; Marianne Staal et al. (2006). Impact of gender on left atrial and ventricular response to asymptornatic aortic valve stenosis. The SEAS study. (ekstern lenke)
• Marcello Chinali; Gerard P. Aurigemma; Peter M. Okin et al. (2010). Hypokalemi blunts left ventricular mass regression in hypertensive patients during losartan- or atenolol-based treatmend: The LIFE echo-substudy. (ekstern lenke)
• Zhibin Li; Kristian Wachtell; Sverre E. Kjeldsen et al. (2007). Gender difference in the association of aortic valve sclerosis and cardiovascular events in hypertensive adults with left ventricular hypertrophy: The LIFE study. (ekstern lenke)
• John Glad Eikås; Eva Gerdts; Helga Bergljot Midtbø et al. (2022). SEX DIFFERENCES IN ARTERIAL FUNCTION IN OBESITY: THE FAT-ASSOCIATED CARDIOVASCULAR DYSFUNCTION STUDY. (ekstern lenke)
• PM Okin; Eva Gerdts; DA Hille et al. (2009). Gender Differences in Outcome During Antihypertensive Therapy in Relation to Regression of Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study. (ekstern lenke)
• Giovanni Cioffi; Giovanni de Simone; Dana Cramariuc et al. (2009). Compensatory or inappropriate left ventricular mass in asymptomatic aortic stenosis. (ekstern lenke)
• H Midtboe; Eva Gerdts; IC Olsen et al. (2013). Does rheumatoid arthritis predispose to abnormal left ventricular geometry independent of hypertension?. (ekstern lenke)
• Costantino Mancusi; Eva Gerdts; Giovanni de Simone et al. (2013). Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment in patients with electrocardiographic left ventricular hypertrophy (LIFE). (ekstern lenke)
• Eva Gerdts; Anne B. Rossebø; Terje R. Pedersen et al. (2009). Impact of severity of aortic valve stenosis on effect of intensive lipid-lowering therapy: The SEAS study. (ekstern lenke)
• Eva Gerdts; Peter M. Okin; Giovanni de Simone et al. (2008). Gender differences in left ventricular structure and function during antihypertensive treatment (the LIFE study). (ekstern lenke)
• Eva Gerdts; P. Okin; K. Wachtell et al. (2010). COMBINED USE OF ELECTROCARDIOGRAM AND ECHOCARDIOGRAM TO BETTER IDENTIFY HYPERTENSIVE PATIENTS AT HIGH RISK FOR HEART FAILURE. (ekstern lenke)
• Marcello Chinali; Gerard P. Aurigemma; Peter M. Okin et al. (2009). Development of Systolic Dysfunction Not Related to Myocardial Infarction in Treated Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Echo Substudy. (ekstern lenke)
• AE Rieck; D Cramariuc; E.M. Staal et al. (2005). Impact of concomitant hypertension on left ventricular structure in patients with aortic valve stenosis. The SEAS study. (ekstern lenke)
• Eva Gerdts; K. Wachtell; Ingrid Os et al. (2004). Clinical and echocardiographic risk factors for congestive heart failure in controlled hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE Study). (ekstern lenke)
• K. Wachtell; Eva Gerdts; V. Palmieri et al. (2004). Does losartan improve diastolic left ventricular function beetter than atenolol during more then four years of antihypertensive treatment? The LIFE Study. (ekstern lenke)
• Eva Gerdts; V. Papademetriou; K. Wachtell et al. (2004). Pulse pressure as cardiovascular risk marker during losartan or atenolol based therapy in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE Trial). (ekstern lenke)
• Lene Vernås Halvorsen; Stine Gognstad; Camilla Lund Søraas et al. (2022). Implications of CYP2D6 polymorphisms for therapeutic drug monitoring in patients with hypertension. (ekstern lenke)
• Einar Skulstad Davidsen; Dana Cramariuc; Øyvind Bleie et al. (2011). Increased systolic strain rate early after transcatheter aortic valve implantation. (ekstern lenke)

Konferanseforedrag

• V Palmieri; JN Bella; K Wachtell et al. (2000). In hypertensive patients with left ventricular hypertrophy inappropriate left ventricular mass identifies high risk phenotypes. (ekstern lenke)
• V Palmieri; K Wachtell; JN Bella et al. (2000). Inappropriate left ventricular mass is associated with high cardiovascular risk profile in hypertensive subjects. (ekstern lenke)
• JN Bella; V Palmieri; K Wachtell et al. (2000). Antihypertensive therapy has greater impact on left ventrular hypertrophy reduction in women than men. (ekstern lenke)
• Eva Gerdts; Hogne Engedal; Jan Erik Nordrehaug (1995). Factors influencing the regression of left ventricular mass in men and women operated for aortic stenosis. (ekstern lenke)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (2000). The effect of losartan treatment on left ventricular hypertrophy in patients with essential hypertension. (ekstern lenke)
• H Björnstad; RB Devereux; Per Omvik et al. (2000). Reduction in left ventricular mass and blood pressure is not accompanied by improved exercise performance in hypertensive patients with left ventricular hypertrophy. (ekstern lenke)
• Eva Gerdts; V. Palmieri; J. E. Otterstad et al. (2001). Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the LIFE study. (ekstern lenke)
• Eva Gerdts; Einar Svarstad; Ole Langeland Myking et al. (1996). Salt sensitivity in hypertensive type-1 diabetes mellitus. (ekstern lenke)
• Eva Gerdts; Ole Langeland Myking; Per Omvik (1994). Plasma atial natriuretic peptide in salt sensitive hypertensive patients. (ekstern lenke)
• Eva Gerdts; Kristian Wachtell; Per Omvik et al. (2003). Left atrial size and risk of major cardiovascular events in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE trial). (ekstern lenke)
• V Palmieri; K Wachtell; JN Bella et al. (2000). Inappropriate left ventricular mass is associated with high cardiovascular risk profile in hypertensive subjects. (ekstern lenke)
• K Wachtell; V Palmieri; MH Olsen et al. (2000). Parallel cardiac and renal damage in patients with left ventricular hypertrophy. (ekstern lenke)
• Eva Gerdts; H. Bjørnstad; S. Toft et al. (1997). Hypertensive women with electrocardiographic left ventricular hypertrophy have Doppler echocardiographic indications of more impaired diastolic left ventricular function compared to men, at rest and during exercise. (ekstern lenke)
• K Wachtell; JN Bella; J Rokkedal et al. (2000). Change in diastolic left ventricular function after one year of antihypertensive treatment. (ekstern lenke)
• H Björnstad; RB Devereux; Per Omvik et al. (2000). Reduction in left ventricular mass and blood pressure is not accompanied by improved exercise performance in hypertensive patients with left ventricular hypertrophy. (ekstern lenke)
• Eva Gerdts; Ole Langeland Myking; Per Omvik (1996). Factors influencing left ventricular mass in hypertense type-1 diabetic patients. (ekstern lenke)
• JN Bella; V Palmieri; K Wachtell et al. (2000). Antihypertensive therapy has greater impact on left ventrular hypertrophy reduction in women than men. (ekstern lenke)
• K Wachtell; JN Bella; J Rokkedal et al. (2000). Change in diastolic left ventricular function after one year of antihypertensive treatment. (ekstern lenke)
• K Wachtell; V Palmieri; MH Olsen et al. (2000). Parallel cardiac and renal damage in patients with left ventricular hypertrophy. (ekstern lenke)
• Ekaterina Sharashova; Tom Wilsgaard; Inger Njølstad et al. (2018). Long-term systolic blood pressure trajectories and incident atrial fibrillation in women and men: The Tromsø Study. (ekstern lenke)
• Ekaterina Sharashova; Tom Wilsgaard; Inger Njølstad et al. (2018). Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study. (ekstern lenke)
• Eva Gerdts; Per Lund-Johansen; Per Omvik (2000). The effect of losartan treatment on left ventricular hypertrophy in patients with essential hypertension. (ekstern lenke)
• V Palmieri; JN Bella; K Wachtell et al. (2000). In hypertensive patients with left ventricular hypertrophy inappropriate left ventricular mass identifies high risk phenotypes. (ekstern lenke)
• Eva Gerdts; Kristian Wachtell; Jennifer E. Liu et al. (2002). The impact of concomitant diabtes on changes in left ventricular structure and function during antihypertensive treatment (the LIFE study). (ekstern lenke)
• Kristian Wachtell; Eva Gerdts; Vittorio Palmieri et al. (2002). Endocardial as well as midwll fractional shortening predict cardiovascular outcome in hypertension: The LIFE study. (ekstern lenke)

Leserbrev

• Anne B. Rossebo; Eva Gerdts; Terje R. Pedersen (2009). Aortic valve stenosis. (ekstern lenke)
• Giovanni de Simone; Costantino Mancusi; Mai Tone Lønnebakken et al. (2018). Reply. (ekstern lenke)
• Helga Bergljot Midtbø; Anne Grete Semb; Knut Matre et al. (2016). Response to: 'Disease activity and left ventricular systolic function in rheumatoid arthritis' by Giollo et al. (ekstern lenke)
• Ester Anne Kringeland; Grethe S. Tell; Helga Bergljot Midtbø et al. (2021). Response to 'Letter to the Editor' by Rognstad et al.. (ekstern lenke)
• G Cioffi; Dana Cramariuc; Morten Dalsgaard et al. (2012). Proper Use of Left Atrial Ejection Force as a Measure of Left Atrial Mechanical Function Reply. (ekstern lenke)
• Nikolaus Jander; Jan Minners; Franz-Josef Neumann et al. (2011). Response to Letters Regarding Article, "Outcome of Patients With Low-Gradient "Severe" Aortic Stenosis and Preserved Ejection Fraction". (ekstern lenke)

Konferanseposter

• Mai Tone Lønnebakken; Øyvind Bleie; Elin Strand et al. (2007). Asessment of Coronary Artery Stenoses by Myocardial Contrast Stress Echocardiography. (ekstern lenke)
• Eva Staal; Per Omvik; Einar S Davidsen et al. (2003). Comparison of blood pressure measurements by the Keito machine to casual blood pressure measured by physicians. (ekstern lenke)
• Ziben Li; Richard B Devereux; Kristian Wachtell et al. (2003). Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: The LIFE study. (ekstern lenke)
• Merethe Visnes; Per Omvik; Sylvi Aanderud et al. (1999). Factors influencing cardiac hypertrophy in type-1 diabetes mellitus. (ekstern lenke)
• Hanne Flagtvedt; Ester Anne Kringeland; Christian Moltu et al. (2025). Kjønnsforskjeller i kardiovaskulære risikofaktorer og mental helse etter perkutan koronar intervensjon. (ekstern lenke)
• EA Kringeland; Grethe S. Tell; H Midtbo et al. (2019). Predictors and covariables of increase in systolic blood pressure in women and men over a 6-year period in midlife: the Hordaland Health Study. (ekstern lenke)
• Kristian Wachtell; Vittorio Palmieri; Eva Gerdts et al. (2003). Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy: The LIFE study. (ekstern lenke)
• Eva Gerdts; Mary J Roman; Vittorio Palmieri et al. (2003). Older age does not attenuate hypertrophy regression during antihypertensive treatment in hypertensive patients with left ventricular hypertrophy. (ekstern lenke)
• E Svarstad; Eva Gerdts; Per Omvik et al. (1995). Captopril and Doxazosin induce similar changes in renal hemodynamics in ambulatory hypertensive patients with insulin dependent diabetes mellitus (IDDM). (ekstern lenke)
• Hilde Espnes; Jocasta Ball; Maja-Lisa Løchen et al. (2022). Risk factors and prognosis for heart failure in atrial fibrillation subtypes in women and men. (ekstern lenke)
• Vasilios Papademetriou; Kristian Wachtell; Eva Gerdts et al. (2003). Left ventricular mass changes in patients with isolated systolic or combined hypertension and electrocardiographic left ventricular hypertrophy: The LIFE study. (ekstern lenke)
• Kurt Boman; Marie Olofsson; Bjørn Dahlöf et al. (2003). Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy: The LIFE study. (ekstern lenke)
• Einar S Davidsen; Eva Gerdts (2003). reproduserbarhet av pulset vevs-Doppler målinger hos pasienter med hemokromatose. (ekstern lenke)
• Ekaterina Sharashova; Tom Wilsgaard; Jocasta Ball et al. (2020). Sex-specific temporal trends in the incidence of atrial fibrillation in a large Norwegian population-based study 1986-2014. (ekstern lenke)
• Birgit Schulz; Anders Hervold; Stig Frode Samnøy et al. (2005). 3T MRI of patients with coronary artery disease. (ekstern lenke)
• Kristian Wachtell; Eva Gerdts; Vittorio Palmieri et al. (2003). Systolic left ventricular function improves more by beta-blockade than losartan: The LIFE study. (ekstern lenke)
• Dana Cramariuc; Åshild Elseth Rieck; Giovanni Cioffi et al. (2011). Impact of valvuloarterial impedance on cardiovascular outcome in patients with asymptomatic aortic stenosis. The SEAS study. (ekstern lenke)

Populærvitenskapelig artikkel

• I. Os; S Oparil; SE Kjeldsen et al. (2005). Female sex and effect of losartan versus atenolol in patients with hypertension and left ventricular hypertrophy. The LIFE study. (ekstern lenke)
• D Cramariuc; AE Rieck; E.M. Staal et al. (2005). Impact of gender on left ventricular geometery and function in mild and moderate asymptomatic aortic valve stenosis. The SEAS study. (ekstern lenke)

Fagartikkel

• Eva Gerdts; Maja-Lisa Løchen (2020). Utfordringer for klinisk forskning -mye mer enn Covid-19. (ekstern lenke)

Fagbok

• Maja-Lisa Løchen; Eva Gerdts (2015). Kvinnehjerter En medisinsk fagbok om vanlige hjertesykdommer. (ekstern lenke)
• Angela H.E.M. Maas; Eva Gerdts (2024). Manual of cardiovascular disease in women. (ekstern lenke)

Doktorgradsavhandling

• Eva Gerdts (1999). The influence of dietary salt intake on blood pressure and left ventricular mass in essential hypertension and hypertensive type-1 diabetic patients. (ekstern lenke)
• Sahrai Saeed; Eva Gerdts (2016). Aortic stiffness and ambulatory blood pressure for cardiovascular risk assessment in young ischemic stroke patients. Insights from the Norwegian Stroke in the Young Study. (ekstern lenke)
• Eva Gerdts; Hilde Halland (2019). Fitness in fatness : Associations with cardiovascular risk factors and subclinical disease. (ekstern lenke)
• Dana Cramariuc; Eva Gerdts; Knut Matre (2009). Left ventricular structure and systolic function in aortic valve stenosis : influence of global left ventricular load, gender and hypertension. (ekstern lenke)
• Helga Bergljot Midtbø; Eva Gerdts (2016). Subclinical cardiovascular disease in patients with rheumatoid arthritis. Relation to disease activity and cardiovascular risk factors. (ekstern lenke)

Deltakelse i radio eller TV

• En podcast om kvinnehelse Femihelse; Maja-Lisa Løchen; Eva Gerdts (2022). Kvinnehjertet Livepodcast fra Kvinnehelsehuset Arrangementet er et samarbeid mellom Kvinnehelseutvalget, Norske Kvinners Sanitetsforening og Femihelse – en podcast om kvinnehelse. (ekstern lenke)

Lederartikkel

• Mai Tone Lønnebakken; Eva Gerdts; Ole Martin Pedersen (2012). Femoral pseudoaneurysm with a communicating arteriovenous fistula: a complication after percutaneous coronary intervention. (ekstern lenke)
• Eva Gerdts (2012). Left atrial enlargement - A prevalent marker of hypertensive heart disease. (ekstern lenke)
• Eva Gerdts; Helga Bergljot Midtbø (2023). Time to Integrate Sex in Management of Aortic Valve Stenosis. (ekstern lenke)
• Helga Bergljot Midtbø; Eva Gerdts (2022). Sex disparities in blood pressure development: Time for action. (ekstern lenke)
• Sahrai Saeed; Eva Gerdts (2018). Incremental prognostic value of left atrial function indices in the prediction of incident atrial fibrillation in patients with ST-elevation myocardial infarction. (ekstern lenke)

Forelesning

• Eva Gerdts (2023). Kvinner og hjertesykdom. (ekstern lenke)

Medieintervju

• Siw Ch. Teigland; Maja-Lisa Løchen; Eva Gerdts (2015). 1 av 3 kvinner rammes av hjertesykdom. Nå er Marit i god hjerteform igjen. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.

FEMALE HEART project (kvinnehjerteprosjektet)

Prosjektet startet i 2012 som et samarbeid mellom vår forskergruppe og forskergrupper ved Norges arktiske universitet i Tromsø og Federico II Universitetet i Napoli, Italia. Prosjektet er translasjonelt og omfatter både dyreeksperimentelle og kliniske studier. Fokus er å forstå hvorfor høyt blodtrykk er mer skadelig for kvinnehjertet, og nye metoder for tidlig påvisning av slik hjerteskade. Prosjektet pågår fortsatt. En årlig Female Heart workshop arrangeres ved UiB for å spre ny kunnskap fra prosjektet. 

Helseundersøkelsen i Hordaland - 3. runde (HUSK3)

Ble gjennomført 2018-22. Fokus på hvordan høyt blodtrykk i 40 årene påvirker kvinner og menns helse når de er 20 år eldre. Oppfølging av 2192 personer. Prosjektet er et samarbeid mellom 5 forskergrupper ved UiB og Helse-Bergen. 

Fedmeassosiert hjertekardysfunksjon (FATCOR)

Fokus på hvordan fedme påvirker hjertets- og pulsårenes funksjon hos kvinner og menn. Tverrsnittsundersøkelse av 618 friske personer med fedme. Prosjektet er et samarbeid mellom 5 forskergrupper ved UiB og Helse-Bergen. En oppfølgingsundersøkelse av deltakerne starter 2022. Fokus er endring av blodtrykk midt i livet, hvilke faktorer som har betydning for at blodtrykket stiger, og kartlegging av underliggende mekanismer.

Norwegian Stroke in the Young Studien (NORSYS) - 5 års studien

Studien er et samarbeid mellom forskere ved nevrologisk avdeling og hjerteavdelingen, Haukeland Universitetssykehus og Klinisk institutt 2. Prosjektet startet i 2010 og 385 pasienter ble rekruttert i perioden 2010-15. Disse ble invitert til en substudie hvor blodtrykk og arteriestivhet ble kontrollert påny etter 5 år.